Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by H. Oelschläger
Markov-Modeling for the Administration of Platinum Analogues and Paclitaxel as First-Line Chemotherapy as Well as Topotecan and Liposomal Doxorubicin as Second-Line Chemotherapy With Epithelial Ovarian Carcinoma
Journal of Cancer Research and Clinical Oncology
Medicine
Cancer Research
Oncology
Related publications
Triplet Chemotherapy With Paclitaxel, Gemcitabine, and Cisplatin as Second-Line Therapy for Advanced Urothelial Carcinoma
Modern Chemotherapy
Weekly Paclitaxel as Second-Line Chemotherapy for Advanced or Recurrent Gastric Cancer
Gastric Cancer
Cancer Research
Medicine
Oncology
Gastroenterology
Ramucirumab Combined With Paclitaxel as the Second-Line Chemotherapy for Elderly Patients With Disseminated Gastric Cancer
Medical Council
P109 Combined Chemotherapy Versus Topotecan Monotherapy as Second-Line Treatment for Patients With Sensitive Relapsed SCLC
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Capecitabine and Irinotecan as First- Line Chemotherapy for Patients With Metastatic Colorectal Cancer
Journal of IMAB - Annual Proceeding (Scientific Papers)
Dentistry
Extending the Platinum‐Free Interval in Recurrent Ovarian Cancer: The Role of Topotecan in Second‐Line Chemotherapy
Oncologist
Cancer Research
Medicine
Oncology
Treatment of Metastatic Germ Cell Tumors With Etoposide and Cisplatin as First Line Chemotherapy
Japanese Journal of Urology
Urology
Phase II Study of Second-Line Chemotherapy With Paclitaxel, Gemcitabine, and Cisplatin for Advanced Urothelial Carcinoma
Anticancer Research
Medicine
Cancer Research
Oncology
Intensive Sequential Dose Dense Chemotherapy With Stem Cell Support as First-Line Treatment in Advanced Ovarian Carcinoma: A Phase II Study
Bone Marrow Transplantation
Transplantation
Hematology
